CFTR and cystic fibrosis: Effects of exogenous type I and III interferons on CF-neutrophil antifungal effector function was further characterised.<h4>Findings</h4>CFTR modulator (ETI) therapy was associated with a significant reduction in Aspergillus biomarkers alongside use of corticosteroid and anti-fungal therapy.